Global Allergy Immunotherapy Market Share, Size, Key Trends, Company Profiles, Regional Industry Analysis, Segmentation and Forecast, 2019-2026

Report Summary

Eternity Insights has published a new study on Global Allergy Immunotherapy Market focusing on key segments as by Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Other), by Application (Allergic Rhinitis, Allergic Asthma, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Allergy Immunotherapy Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Allergy Immunotherapy Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Allergy Immunotherapy Market Size, 2018-2028 (USD Million)

Global Allergy Immunotherapy Market Segmentation:

Allergy Immunotherapy Market, By Type

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy
• Other

Allergy Immunotherapy Market, By Application

• Allergic Rhinitis
• Allergic Asthma
• Other

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Allergy Immunotherapy market in terms of demand generation. The Allergy Immunotherapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Allergy Immunotherapy market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Allergy Immunotherapy Market Taxonomy:

Global Allergy Immunotherapy Market Competitive Landscape

The global Allergy Immunotherapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abell� A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents
1 Allergy Immunotherapy Market Overview
1.1 Allergy Immunotherapy Product Overview
1.2 Allergy Immunotherapy Market Segment by Type
1.2.1 Subcutaneous Immunotherapy
1.2.2 Sublingual Immunotherapy
1.3 Global Allergy Immunotherapy Market Size by Type
1.3.1 Global Allergy Immunotherapy Sales and Growth by Type
1.3.2 Global Allergy Immunotherapy Sales and Market Share by Type (2017-2020)
1.3.3 Global Allergy Immunotherapy Revenue and Market Share by Type (2017-2020)
1.3.4 Global Allergy Immunotherapy Price by Type (2017-2020)
2 Global Allergy Immunotherapy Market Competition by Company
2.1 Global Allergy Immunotherapy Sales and Market Share by Company (2017-2020)
2.2 Global Allergy Immunotherapy Revenue and Share by Company (2017-2020)
2.3 Global Allergy Immunotherapy Price by Company (2017-2020)
2.4 Global Top Players Allergy Immunotherapy Manufacturing Base Distribution, Sales Area, Product Types
2.5 Allergy Immunotherapy Market Competitive Situation and Trends
2.5.1 Allergy Immunotherapy Market Concentration Rate
2.5.2 Global Allergy Immunotherapy Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Allergy Immunotherapy Company Profiles and Sales Data
3.1 ALK-Abello
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Allergy Immunotherapy Product Category, Application and Specification
3.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Stallergenes Greer
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Allergy Immunotherapy Product Category, Application and Specification
3.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Merck
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Allergy Immunotherapy Product Category, Application and Specification
3.3.3 Merck Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Allergy Therapeutics
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Allergy Immunotherapy Product Category, Application and Specification
3.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 HAL
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Allergy Immunotherapy Product Category, Application and Specification
3.5.3 HAL Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 WOLW Pharma
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Allergy Immunotherapy Product Category, Application and Specification
3.6.3 WOLW Pharma Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Holister Stier
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Allergy Immunotherapy Product Category, Application and Specification
3.7.3 Holister Stier Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Leti
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Allergy Immunotherapy Product Category, Application and Specification
3.8.3 Leti Allergy Immunotherapy Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
4 Allergy Immunotherapy Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Allergy Immunotherapy Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Allergy Immunotherapy Sales and Revenue by Regions
4.2.1 Global Allergy Immunotherapy Sales and Market Share by Regions (2017-2020)
4.2.2 Global Allergy Immunotherapy Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Allergy Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Allergy Immunotherapy Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Allergy Immunotherapy Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Allergy Immunotherapy Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Allergy Immunotherapy Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Allergy Immunotherapy Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Allergy Immunotherapy Application/End Users
5.1 Allergy Immunotherapy Segment by Application
5.1.1 Allergic Rhinitis
5.1.2 Allergic Asthma
5.1.3 Other
5.2 Global Allergy Immunotherapy Product Segment by Application
5.2.1 Global Allergy Immunotherapy Sales by Application
5.2.2 Global Allergy Immunotherapy Sales and Market Share by Application (2017-2020)
6 Global Allergy Immunotherapy Market Forecast
6.1 Global Allergy Immunotherapy Sales, Revenue Forecast (2021-2027)
6.1.1 Global Allergy Immunotherapy Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Allergy Immunotherapy Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Allergy Immunotherapy Forecast by Regions
6.2.1 North America Allergy Immunotherapy Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Allergy Immunotherapy Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Allergy Immunotherapy Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Allergy Immunotherapy Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Allergy Immunotherapy Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Allergy Immunotherapy Forecast by Type
6.3.1 Global Allergy Immunotherapy Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Subcutaneous Immunotherapy Growth Forecast
6.3.3 Sublingual Immunotherapy Growth Forecast
6.4 Allergy Immunotherapy Forecast by Application
6.4.1 Global Allergy Immunotherapy Sales Forecast by Application (2021-2027)
6.4.2 Global Allergy Immunotherapy Forecast in Allergic Rhinitis
6.4.3 Global Allergy Immunotherapy Forecast in Allergic Asthma
7 Allergy Immunotherapy Upstream Raw Materials
7.1 Allergy Immunotherapy Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Allergy Immunotherapy Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer